Anthem BCBS Medical Policy Updates – December 2022

Click here to view the Anthem BCBS Blue Cross Blue Shield Medical Policy Updates »

December 2022 Anthem BCBS Medical Policy Updates:

• Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting
• Analysis of Proteomic Patterns
• Angiographic Evaluation and Endovascular Intervention for Dialysis Access Circuit Dysfunction
• Artificial Retinal Devices
• Bariatric Surgery and Other Treatments for Clinically Severe Obesity
• Bone-Anchored and Bone Conduction Hearing Aids
• BRCA Genetic Testing
• Cardiac Resynchronization Therapy with or without an Implantable Cardioverter Defibrillator for the Treatment of Heart Failure
• Circulating Tumor DNA Panel Testing (Liquid Biopsy)
• Clinical Utilization Management (UM) Guideline for Pre-Payment Review Medical Necessity Determinations When No Other Clinical UM Guideline Exists
• Continuous Glucose Monitoring Devices and External Insulin Infusion Pumps
• DME.00048 Virtual Reality-Assisted Therapy Systems
• Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices
• Electrophysiology-Guided Noninvasive Stereotactic Cardiac Radioablation
• Endovascular Techniques (Percutaneous or Open Exposure) for Arterial Revascularization of the Lower Extremities
• External Ambulatory Cardiac Monitors
• Gene Expression Profiling for Bladder Cancer
• Gene Mutation Testing for Cancer Susceptibility and Management
• Genetic Testing for Inherited Diseases
• Home Health
• Intravascular Brachytherapy (Coronary and Non-Coronary)
• Moderate to Deep Anesthesia Services for Dental Surgery in the Facility Setting
• Nasal Valve Suspension
• Open Sacroiliac Joint Fusion
• Outpatient Cystourethroscopy
• Panel and other Multi-Gene Testing for Polymorphisms to Determine Drug-Metabolizer Status
• Peripheral Nerve Blocks for Treatment of Neuropathic Pain
• Protein Biomarkers for the Screening, Detection and Management of Prostate Cancer
• Retinal Telescreening Systems
• Testing for Biochemical Markers for Alzheimer’s Disease
• Therapeutic use of Stem Cells, Blood and Bone Marrow Products
• Viscocanalostomy and Canaloplasty
• Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling

Click here to view the Anthem BCBS Blue Cross Blue Shield Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.